Join Growin Stock Community!

Genedx holdings corp.WGSWW.US Overview

US StockHealthcare
(No presentation for WGSWW)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

WGSWW AI Insights

WGSWW Overall Performance

WGSWW AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

WGSWW Recent Performance

16.09%

Genedx holdings corp.

0.05%

Avg of Sector

-0.31%

S&P500

WGSWW PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

WGSWW Key Information

WGSWW Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

WGSWW Profile

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

Price of WGSWW

WGSWW FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

WGSWW Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.07
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
0.03
METRIC
VALUE
vs. INDUSTRY
Gross Margin
69.65%
Net Margin
0.52%
Revenue Growth (YoY)
50.50%
Profit Growth (YoY)
82.17%
3-Year Revenue Growth
11.94%
3-Year Profit Growth
84.09%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.07
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
0.03
Gross Margin
69.65%
Net Margin
0.52%
Revenue Growth (YoY)
50.50%
Profit Growth (YoY)
82.17%
3-Year Revenue Growth
11.94%
3-Year Profit Growth
84.09%
  • When is WGSWW's latest earnings report released?

    The most recent financial report for Genedx holdings corp. (WGSWW) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating WGSWW's short-term business performance and financial health. For the latest updates on WGSWW's earnings releases, visit this page regularly.

  • Where does WGSWW fall in the P/E River chart?

    According to historical valuation range analysis, Genedx holdings corp. (WGSWW)'s current price-to-earnings (P/E) ratio is -101.59, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of WGSWW?

    According to the latest financial report, Genedx holdings corp. (WGSWW) reported an Operating Profit of -3.25M with an Operating Margin of -2.78% this period, representing a growth of 58.21% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is WGSWW's revenue growth?

    In the latest financial report, Genedx holdings corp. (WGSWW) announced revenue of 116.74M, with a Year-Over-Year growth rate of 51.86%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does WGSWW have?

    At the end of the period, Genedx holdings corp. (WGSWW) held Total Cash and Cash Equivalents of 95.97M, accounting for 0.19 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does WGSWW go with three margins increasing?

    In the latest report, Genedx holdings corp. (WGSWW) did not achieve the “three margins increasing” benchmark, with a gross margin of 72.4%%, operating margin of -2.78%%, and net margin of -6.54%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess WGSWW's profit trajectory and future growth potential.

  • Is WGSWW's EPS continuing to grow?

    According to the past four quarterly reports, Genedx holdings corp. (WGSWW)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.27. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of WGSWW?

    Genedx holdings corp. (WGSWW)'s Free Cash Flow (FCF) for the period is 9.6M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 290.34% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of WGSWW?

    The latest valuation data shows Genedx holdings corp. (WGSWW) has a Price-To-Earnings (PE) ratio of -101.59 and a Price/Earnings-To-Growth (PEG) ratio of 0.59. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.